article thumbnail

9th Advanced GMP Workshop 2024 was organised by IPA

Express Pharma

The post 9th Advanced GMP Workshop 2024 was organised by IPA appeared first on Express Pharma. It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.

article thumbnail

Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023

Express Pharma

In December 2024, the pharma industry reported 82 deals worth $5.2 billion, compared to the last 12-month (December 2023 to November 2024) average of 100 deals worth $16.8 These were the three major deals that contributed 70 per cent of the total deal value during December 2024. billion; AlpInvest Partners B.V.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

JP Nadda inaugurates Jan Aushadhi Diwas celebrations

Express Pharma

At the initiative of Prime Minister Narendra Modi, March 7 is celebrated every year as Jan Aushadhi Diwas to enhance awareness about the scheme and promote generic medicines. Under this scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened to provide generic medicines. to the citizens.

article thumbnail

CHMP meeting highlights: January 2024

European Pharmaceutical Review

The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

The FDA has an established office in India overseeing the number of qualified manufacturers supplying generic medicines to the US. Inspection categorisation of Official Action Indicated (OAI) for Indian companies has decreased to 11 per cent in 2024 from 23 per cent in 2014, aligning with the global trend of 14 per cent in 2024.

article thumbnail

The rise of Fixed-Dose Combinations (FDCs): What it means for pharma players

Express Pharma

This strategy has been particularly prominent in countries like India, which is one of the largest producers of generic medicines and has been a key player in the global FDC market. More recently, in August 2024, another 156 FDCs, including widely used cold and fever medications, were prohibited due to safety concerns.

article thumbnail

CHMP meeting highlights – July 2024

European Pharmaceutical Review

These medicines were recommended by the CHMP to treat plaque psoriasis, paediatric plaque psoriasis, psoriatic arthritis, ulcerative colitis and Crohn’s disease. The post CHMP meeting highlights – July 2024 appeared first on European Pharmaceutical Review. Tuznue (trastuzumab) for breast and gastric cancer.